Immunodiagnostics Market Forecast Assessing Growth Potential And Industry Direction

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Immunodiagnostics Market By 2030?

The immunodiagnostics market has experienced substantial growth in recent years. It is forecast to expand from $24.32 billion in 2025 to $26.16 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.5%. The market’s historical development can be attributed to the increasing prevalence of infectious and chronic diseases, the enlargement of clinical laboratory networks, the rising demand for early disease detection, the growing application of antibody-based diagnostics, and the widespread availability of standardized immunoassay technologies.

The immunodiagnostics market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $35.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period stems from factors such as the greater embrace of personalized diagnostics, increased funding for automated laboratories, the broadening of point-of-care immunodiagnostics, the expanding incorporation of AI for result interpretation, and an intensified focus on preventive healthcare examinations. Key developments anticipated within this timeframe involve the wider deployment of automated immunoassay analyzers, an escalating need for highly sensitive diagnostic tests, the increased utilization of swift immunodiagnostic kits, the broadening of multiplex testing capacities, and improved integration of laboratory data management platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Which Significant Factors Are Encouraging Growth In The Immunodiagnostics Market?

The expansion of the immunodiagnostics market is anticipated to be fueled by the increasing prevalence of chronic diseases. These are enduring health conditions, such as diabetes, heart disease, and arthritis, which typically progress gradually and demand continuous medical attention and lifestyle management for symptom control and complication prevention. The rise in chronic diseases is largely attributable to unhealthy lifestyles, encompassing poor diet, physical inactivity, and smoking, which elevate the risk of conditions like diabetes, heart disease, and obesity. Immunodiagnostics play a crucial role in chronic disease diagnosis by enabling the precise detection of biomarkers and immune responses linked to long-term health issues. They improve the early identification and monitoring of conditions such as diabetes, autoimmune disorders, and cardiovascular conditions, thereby enhancing patient management and supporting timely treatment choices. As an illustration, in June 2024, the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Consequently, the escalating occurrence of chronic diseases is propelling the growth of the immunodiagnostics market.

How Is The Immunodiagnostics Market Structured Across Different Market Segments?

The immunodiagnostics market covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, ELISA Readers

What Trends Are Driving Changes In The Immunodiagnostics Market?

Major companies in the immunodiagnostics market are increasingly prioritizing the development of innovative solutions, such as automated chemiluminescence immunoassays (CLIAs), to enhance diagnostic accuracy, reduce testing time, and improve laboratory efficiency. These automated chemiluminescence immunoassays (CLIAs) are laboratory tests that utilize light-emitting chemical reactions and automation to quickly and accurately detect specific proteins or antibodies in blood or other samples. For instance, in September 2025, DiaSorin S.p.A., an Italy-based diagnostics company, unveiled the LIAISON® TSH-R Ab assay for assessing autoimmune thyroid disorders. This test incorporates features like improved antibody specificity through double-bridge assay architecture, effortless integration into existing LIAISON analyzers to streamline laboratory workflows, and CE-marked compatibility enabling deployment across multiple regulated regions.

Who Are The Key Market Participants In The Immunodiagnostics Market?

Major companies operating in the immunodiagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMérieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., Immunodiagnostic Systems Holdings Plc (IDS)

Access The Complete Immunodiagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Which Region Holds The Largest Share In The Immunodiagnostics Market?

North America was the largest region in the immunodiagnostics market in 2025. The regions covered in the immunodiagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Immunodiagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Browse Through More Reports Similar to the Global Immunodiagnostics Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795